Approval · Notice of Compliance 3495 · 2003
CO-RANITIDINE: Notice of Compliance 3495
Issued December 24, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3495
- Date
- December 24, 2003
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Histamine H2-receptor antagonist
- Canadian reference product
- ZANTAC
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CO-RANITIDINE | 02248570 | Cancelled Post Market |
| CO-RANITIDINE | 02248571 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB